Clinical Trial Update: A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the relationship between albuterol multidose dry powder inhaler use with an eModule (eMDPI) and exacerbations in participants with asth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• albuterol multidose dry powder inhaler (albuterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-05-03